SLA 0.00% $3.34 silk laser australia limited

And the results of their phase II trial with Ropren...

  1. 52 Posts.
    And the results of their phase II trial with Ropren demonstrating clear efficacy in the treatment of liver disease (which would need biopsy or imaging results showing clear changes in cellular morphology - not the change in a couple of blood markers of liver function) are to be found where????
 
watchlist Created with Sketch. Add SLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.